Latest News
Steel is a cyclical business, and right now, business isn't great.
Via The Motley Fool · May 8, 2025
Via The Motley Fool · May 8, 2025
Joby stock lost less money than feared. That's a good thing, but the stock remains risky.
Via The Motley Fool · May 8, 2025
SPX futures rose to 5698.40 this morning, just points away from the retracement high at 5700.70 made last Friday.
Via Talk Markets · May 8, 2025
Home standby generators are expected to continue growing in 2025, driven by an increase in activations in the first half and higher pricing beginning in the second half.
Via Talk Markets · May 8, 2025
The primary reason for the lower loss per share and higher revenue was the sale of a quantum computing system worth $12.20 million during the quarter.
Via Stocktwits · May 8, 2025
The market liked its recent update, but it will take more than that for the company to rebound.
Via The Motley Fool · May 8, 2025
The company estimates adjusted diluted earnings per share for FY25 to be about flat compared to FY24, when it reported a profit of $1.14 per share.
Via Stocktwits · May 8, 2025
Via The Motley Fool · May 8, 2025
Via The Motley Fool · May 8, 2025
After a weak opening, Indian benchmark indices extended their losses throughout the session in the red.
Via Talk Markets · May 8, 2025
Via The Motley Fool · May 8, 2025
Via The Motley Fool · May 8, 2025
Semiconductor maker Himax Technologies (NASDAQ:HIMX) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 3.7% year on year to $215.1 million. On top of that, next quarter’s revenue guidance ($237.2 million at the midpoint) was surprisingly good and 14.1% above what analysts were expecting. Its GAAP profit of $0.11 per share was 31.5% above analysts’ consensus estimates.
Via StockStory · May 8, 2025
Tapestry Inc (NYSE:TPR) revenue rose 7% to $1.58B. Coach drove 15% revenue growth in constant currency.
Via Benzinga · May 8, 2025
Oil rebound possible soon if US-China trade tensions ease. OPEC surprise output boost and declining US shale production could tighten supply.
Via Benzinga · May 8, 2025
Medication company Viatris (NASDAQ:VTRS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 11.2% year on year to $3.25 billion. The company’s full-year revenue guidance of $13.75 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.50 per share was in line with analysts’ consensus estimates.
Via StockStory · May 8, 2025
The company expects the acquisition to add diversity and durability to its trading revenues, given that options trading revenues are typically less cyclical than spot trading.
Via Stocktwits · May 8, 2025